Brian H Dovey - Net Worth and Insider Trading
Brian H Dovey Net Worth
The estimated net worth of Brian H Dovey is at least $82 Million dollars as of 2024-06-05. Brian H Dovey is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $54 Million. Brian H Dovey is the 10% Owner of Zogenix Inc and owns about 825,323 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Brian H Dovey is also the 10% Owner of Esperion Therapeutics Inc and owns about 2,102,188 shares of Esperion Therapeutics Inc (ESPR) stock worth over $5 Million. Besides these, Brian H Dovey also holds Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Orexigen Therapeutics Inc (OREXQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) , Align Technology Inc (ALGN) . Details can be seen in Brian H Dovey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian H Dovey has not made any transactions after 2013-08-27 and currently still holds the listed stock(s).
Transaction Summary of Brian H Dovey
Brian H Dovey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian H Dovey owns 32 companies in total, including Obalon Therapeutics Inc (OBLN) , Adynxx Inc (ADYX) , and Bionano Genomics Inc (BNGO) among others .
Click here to see the complete history of Brian H Dovey’s form 4 insider trades.
Insider Ownership Summary of Brian H Dovey
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
ADYX | Adynxx Inc | 2019-05-03 | 10 percent owner |
BNGO | Bionano Genomics Inc | 2018-08-21 | 10 percent owner |
2017-12-18 | 10 percent owner | ||
2017-12-11 | 10 percent owner | ||
2017-07-14 | director | ||
2016-11-01 | 10 percent owner | ||
2016-09-09 | 10 percent owner | ||
2013-09-24 | 10 percent owner | ||
2016-03-02 | 10 percent owner | ||
2015-06-24 | 10 percent owner | ||
2014-08-12 | director & 10 percent owner | ||
2015-05-06 | 10 percent owner | ||
2013-07-01 | 10 percent owner | ||
2014-11-19 | 10 percent owner | ||
2014-10-15 | 10 percent owner | ||
2013-10-29 | 10 percent owner | ||
2014-07-31 | 10 percent owner | ||
2014-05-01 | 10 percent owner | ||
2014-03-17 | 10 percent owner | ||
2011-06-02 | 10 percent owner | ||
2013-11-13 | 10 percent owner | ||
2011-11-21 | 10 percent owner | ||
2013-01-18 | 10 percent owner | ||
2013-01-14 | 10 percent owner | ||
2011-09-16 | 10 percent owner | ||
2006-05-09 | 10 percent owner | ||
2006-04-12 | 10 percent owner | ||
2004-06-25 | 10 percent owner | ||
2003-08-08 | director | ||
2004-05-12 | 10 percent owner | ||
2016-10-05 | 10 percent owner |
Brian H Dovey Latest Holdings Summary
Brian H Dovey currently owns a total of 10 stocks. Among these stocks, Brian H Dovey owns 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) as of August 20, 2010, with a value of $54 Million and a weighting of 65.85%. Brian H Dovey owns 825,323 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 26.7%. Brian H Dovey also owns 2,102,188 shares of Esperion Therapeutics Inc (ESPR) as of July 1, 2013, with a value of $5 Million and a weighting of 5.81%. The other 7 stocks Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Orexigen Therapeutics Inc (OREXQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) , Align Technology Inc (ALGN) have a combined weighting of 1.64% among all his current holdings.
Latest Holdings of Brian H Dovey
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACHN | Achillion Pharmaceuticals Inc | 2010-08-20 | 8,032,129 | 6.76 | 54,297,192 |
ZGNX | Zogenix Inc | 2010-11-29 | 825,323 | 26.68 | 22,019,618 |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 2,102,188 | 2.28 | 4,792,989 |
ALIM | Alimera Sciences Inc | 2011-06-02 | 279,297 | 3.08 | 860,235 |
OCRX | Ocera Therapeutics Inc | 2013-07-15 | 246,386 | 1.79 | 441,031 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,041,950 | 0.02 | 45,629 |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 301,806 | 0.01 | 1,600 |
NOVCQ | Novation Companies Inc | 2006-05-15 | 1,062,474 | 0.00 | 106 |
RGDO | Regado Biosciences Inc | 2013-08-27 | 2,603,208 | 0.00 | 0 |
ALGN | Align Technology Inc | 2003-08-08 | 0 | 254.71 | 0 |
Holding Weightings of Brian H Dovey
Brian H Dovey Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian H Dovey has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on August 20, 2010, which brought Brian H Dovey around $0.
According to the SEC Form 4 filings, Brian H Dovey has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost Brian H Dovey around $9 Million.
According to the SEC Form 4 filings, Brian H Dovey has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 285,714 shares on July 1, 2013, which cost Brian H Dovey around $4 Million.
More details on Brian H Dovey's insider transactions can be found in the Insider Trading History of Brian H Dovey table.Insider Trading History of Brian H Dovey
- 1
Brian H Dovey Trading Performance
GuruFocus tracks the stock performance after each of Brian H Dovey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian H Dovey is 14.16%. GuruFocus also compares Brian H Dovey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian H Dovey within 3 months outperforms 6 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian H Dovey's insider trading performs compared to the benchmark.
Performance of Brian H Dovey
Brian H Dovey Ownership Network
Ownership Network List of Brian H Dovey
Ownership Network Relation of Brian H Dovey
Brian H Dovey Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Brian H Dovey is the 10 percent owner of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Retail Officer Robert J Macdonald .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Brian H Dovey Mailing Address
Above is the net worth, insider trading, and ownership report for Brian H Dovey. You might contact Brian H Dovey via mailing address: One Palmer Square, Princeton Nj 08542.